+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A quantitative approach to benefit-risk assessment of medicines--part 1: the development of a new model using multi-criteria decision analysis; part 2: the practical application of a new model



A quantitative approach to benefit-risk assessment of medicines--part 1: the development of a new model using multi-criteria decision analysis; part 2: the practical application of a new model



Pharmacoepidemiology and Drug Safety 16(Suppl. 1): S42




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051225665

Download citation: RISBibTeXText

PMID: 17546572

DOI: 10.1002/pds.1436


Related references

A quantitative approach to benefit-risk assessment of medicines - part 1: the development of a new model using multi-criteria decision analysis. Pharmacoepidemiology and Drug Safety 16 Suppl 1(): S2-S15, 2007

A quantitative approach to benefit-risk assessment of medicines--part 2; the practical application of a new model. Pharmacoepidemiology and Drug Safety 16(10): 1180-1180, 2007

A quantitative benefit-risk assessment approach to improve decision making in drug development: Application of a multicriteria decision analysis model in the development of combination therapy for overactive bladder. Clinical Pharmacology and Therapeutics 99(4): 442-451, 2016

A Note on the Validity and Reliability of Multi-Criteria Decision Analysis for the Benefit-Risk Assessment of Medicines. Drug Safety 38(11): 1049-1057, 2015

Prescribers' compliance is part of benefit-risk assessment of medicines and it can lead to failure of risk minimization measures and withdrawals of medicines. Current Medical Research and Opinion 2018: 1-2, 2018

Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis. Clinical Therapeutics 41(2): 249-260.E18, 2019

Decision analysis utilizing data from multiple life-cycle impact assessment methods Part II: Model development. Journal of Industrial Ecology 8(1-2): 119-141, Winter, 2004

Use of A Multi-Decision Criteria Analysis to Support Healthcare Decision-Making for Private Payers in Brazil: Development of a Model To Guide Reimbursement Decisions. Value in Health 18(7): A730, 2015

Path analysis and multi-criteria decision making: an approach for multivariate model selection and analysis in health. Annals of Epidemiology 11(6): 377-384, 2001

Marriage of a medium-term liver model to surrogate markers--a practical approach for risk and benefit assessment. Toxicologic Pathology 27(2): 237-242, 1999

Development of a site-specific Ecological Risk Assessment for contaminated sites: part II. A multi-criteria based system for the selection of bioavailability assessment tools. Science of the Total Environment 379(1): 34-45, 2007

Integration of environmental and human health risk assessment for industries using hazardous materials: a quantitative multi criteria approach for environmental decision makers. Environment International 37(2): 393-403, 2011

Expert judgment based multi-criteria decision model to address uncertainties in risk assessment of nanotechnology-enabled food products. Journal of Nanoparticle Research 13(5): 1813-1831, 2011

Environmental risk-based ranking of solvents using the combination of a multimedia model and multi-criteria decision analysis. Green Chemistry 19(4): 1034-1042, 2017

Land Suitability Analysis for Rice Cultivation Using a GIS-based Fuzzy Multi-criteria Decision Making Approach: Central Part of Amol District, Iran. Soil and Water Research 12(1): 29-38, 2017